Review article: Rebamipide and the digestive epithelial barrier

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 18, Issue 1, 2003, Pages 55-62

  Matysiak Budnik, T ^a   Heyman, M ^a   Megraud F ^b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOOD ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; REBAMIPIDE; ALANINE; ANTIULCER AGENT; BACTERIAL ANTIGEN; DRUG DERIVATIVE; QUINOLONE DERIVATIVE;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; CELL MEMBRANE TRANSPORT; CONFERENCE PAPER; DIET; DIGESTIVE SYSTEM; DISEASE PREDISPOSITION; ENTERITIS; FOOD ALLERGY; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; INTESTINE EPITHELIUM; INTESTINE MUCOSA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SENSITIZATION; DRUG EFFECT; EPITHELIUM CELL; IMMUNOLOGY; INTESTINE ABSORPTION; METABOLISM; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ALANINE; ANTI-ULCER AGENTS; ANTIGENS, BACTERIAL; BIOLOGICAL TRANSPORT; DIGESTIVE SYSTEM; EPITHELIAL CELLS; HELICOBACTER PYLORI; HUMANS; INTESTINAL ABSORPTION; QUINOLONES;

EID: 0242684453     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.18.s1.6.x     Document Type: Conference Paper

References (52)

1. Teorell T. On the permeability of the stomach for acids and some other substances. J Gen Physiol 1939; 23: 263-74.
2. Davenport HW, Warner HA, Code CF. Functional significance of gastric mucosal barrier to sodium. Gastroenterology 1968; 54(Suppl. 11): 709-11.
3. Davenport HW. Gastric mucosal injury by fatty and acetyl-salicylic acid. Gastroenterology 1964; 46: 245-53.
4. Hollander F. The two-component mucus barrier: Its activity in protecting the gastroduodenal mucosa against peptic ulceration. Arch Intern Med 1954; 93: 107-20.
5. Ivey KJ. Gastric mucosal barrier. Gastroenterology 1971; 61: 247-57.
6. Crowe SE, Luthra GK, Perdue MH. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Gut 1997; 41: 785-92.
7. Mitomi H, Tanabe S, Igarashi M, et al. Autoimmune enteropathy with severe atrophic gastritis and colitis in an adult: proposal of a generalized autoimmune disorder of the alimentary tract. Scand J Gastroenterol 1998; 33: 716-20.
8. Schmitz H, Barmeyer C, Fromm M, et al. Altered tight junction structure contributes to the hnpaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999; 116: 301-9.
9. Soler AP, Miller RD, Laughlin KV, et al. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999; 20: 1425-31.
10. Gotteland M, Isolauri E, Heyman M, Tome D, Desjeux JF. Antigen absorption in bacterial diarrhea: in vivo intestinal transport of β-lactoglobulin in rabbits infected with the entero-adherent Escherichia coli strain RDEC-1. Pediatr Res 1989; 26: 237-40.
11. Heyman M, Corthier G, Petit A, et al. Intestinal absorption of macromolecules during viral enteritis: an experimental study on rotavirus-infected conventional and germ-free mice. Pediair Res 1987; 22: 72-8.
12. Crowe SE, Perdue MH. Gastrointestinal food hypersensitivity, basic mechanisms of pathophysiology. Gastroenterology 1992; 103: 1075-95.
13. Heyman M, Grasset E, Ducroc R, Desjeux JF. Antigen absorption by the jejunal epithelium of children with cow's milk allergy. Pediatr Res 1988; 24: 197-202.
14. Tobey NA, Hosseini SS, Caymaz-Bor C, et al. The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol 2001; 96: 3062-70.
15. Davies NM. Review article: nonsteroidal anti-inflammatory drug-induced gastrointestinal permeability. Aliment Pharmacol Ther 1998; 12: 303-20.
16. Kiviluoto T, Mustonen H, Kivilaakso E. Effect of barrier-breaking agents on intracellular pH and epithelial membrane resistances: studies in isolated Necturus antral mucosa exposed to luminal acid. Gastroenterology 1989; 96: 1410-8.
17. Segal ED, Shon J, Tompkins LS. Characterization of Helicobacter pylori urease mutants. Infect Immun 1992; 60: 1883-9.
18. Terres AM, Pajares JM, Hopkins AM, et al. Helicobacter pylori disrupts epithelial barrier function in a process inhibited by protein kinase C activators. Infect Immun 1998; 66: 2943-50.
19. Borch K, Sjostedt C, Hannestad U, et al. Asymptomatic Helicobacter pylori gastritis is associated with increased sucrose permeability. Dig Dis Sci 1998; 43: 749-53.
20. Matysiak-Budnik T, Terpend K, Alain S, et al. Helicobacter pylori alters exogenous antigen absorption and processing across a digestive epithelial cell line. Infect Immun 1998; 66: 5785-91.
21. Matysiak-Budnik T, Hashimoto K, Heyman M, et al. Antral gastric permeability to antigens in mice is altered by infection with Helicobacter felis. Eur J Gastroenterol Hepatol 1999; 11: 1371-7.
22. Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K. Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Dig Dis Sci 1995; 40: 2469-72.
23. Hahm KB, Lee KJ, Kim YS, et al. Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori. Dig Dis Sci 1998; 43: 192S-7S.
24. Nomura H, Miyake K, Kashiwagi S, Sugiyama T, Asaka M. A short-term eradication therapy for Helicobacter pylori acute gastritis. J Gastroenterol Hepatol 2000; 15: 1377-81.
25. Kishimoto S, Haruma K, Tari A, et al. Rebamipide, an anti-ulcer drug, prevents DSS-induced colitis formation in rats. Dig Dis Sci 2000; 45: 1608-16.
26. Makiyama K, Takeshima F, Kawasaki H, Zea-Iriarte WL. Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative. Am J Gastroenterol 2000; 95: 1838-9.
27. Naito Y, Yoshikawa T, Tanigawa T, et al. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Rad Biol Med 1995; 18: 117-23.
28. Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S. Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in rat. Eur J Pharmacol 1987; 142: 29.
29. Aihara M, Imagawa K, Funakoshi Y, Ohmoto Y, Kikuchi M. Effects of rebamipide on production of several cytokines by human peripheral blood mononuclear cells. Dig Dis Sci 1998; 43: 160S-6S.
30. Nagano C, Wakebe H, Azuma A, Imagawa K, Kikuchi M. IFN-gamma-induced iNOS mRNA expression is inhibited by rebamipide in murine macrophage RAW264.7 cells. Dig Dis Sci 1998; 43: 1188-248.
31. Walker WA, Cornell R, Davenport LM, Isselbacher KJ. Macromolecular absorption. Mechanism of horseradish peroxidase uptake and transport in adult and neonatal rat intestine. J Cell Biol 1972; 54: 195-205.
32. Ducroc R, Heyman M, Beaufrere B, Morgat JL, Desjeux JF. Horseradish peroxidase transport across rabbit jejunum and Peyer's patches in vitro. Am J Physiol 1983; 245: G54-G58.
33. Heyman M, Ducroc R, Desjeux JF, Morgat JL. Horseradish peroxidase transport across adult rabbit jejunum in vitro. Am J Physiol 1982; 242: G558-64.
34. Heyman M, Boudraa G, Sarrut S, et al. Macromolecular transport in jejunal mucosa of children with severe malnutrition: a quantitative study. J Pediatr Gastroenterol Nutr 1984; 3: 357-63.
35. Heyman M, Crain-Denoyelle AM, Nath SK, Desjeux JF. Quantification of protein transcytosis in the human colon carcinoma cell line CaCo-2. J Cell Physiol 1990; 143: 391-5.
36. Heyman M, Desjeux JF. Significance of intestinal food protein transport. J Pediatr Gastroenterol Nutr 1992; 15: 48-57.
37. Naito Y, Yoshikawa T, Iinuma S, et al. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study. Dig Dis Sci 1998; 43: 83S-9S.
38. Naito Y, Yoshikawa T, Matsuyama K, et al. Effect of rebamipide, a novel anti-ulcer agent, on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Pathopysiology 1994; 1: 161-4.
39. Kokura S, Yoshikawa T, Naito Y, et al. Effect of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats. Digest Dis Sci 1997; 42: 2566-71.
40. Kurokawa T, Joh T, Ikai M, et al. Rebamipide protects against oxygen radical-mediated gastric mucosal injury in rats. Dig Dis Sci 1998; 43: 113S-7S.
41. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66: 5964-71.
42. El Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
43. Matysiak-Budnik T, Thomas-Collignon A, Megraud F, Heyman M. Alterations of epithelial permeability by Helicobacter and IL-1β in vitro: protective effect of rebamipide. Dig Dis Sci 2001; 46: 1558-66.
44. Hayashi S, Sugiyama T, Amano K, et al. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells. Antimicrob Agents Chemother 1998; 42: 1895-9.
45. Matysiak-Budnik T, de Mascarel A, Abely M, et al. Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis. Scand J Gastroenterol 2000; 35: 470-5.
46. Han BG, Kim HS, Rhee KH, Han HS, Chung MH. Effects of rebamipide on gastric cell damage by Helicobacter pylori-stimulated human neutrophils. Pharmacol Res 1995; 32: 201-7.
47. Yoshida N, Yoshikawa T, Iinuma S, et al. Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig Dis Sci 1996; 41: 1139-44.
48. Corrado G, Luzzi I, Lucarelli S, et al. Positive association between Helicobacter pylori infection and food allergy in children. Scand J Gastroenterol 1998; 33: 1135-9.
49. Figura N, Perrone A, Gennari C, et al. Food allergy and Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1999; 31: 186-91.
50. Aihara M, Azuma A, Takizawa H, et al. Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig Dis Sci 1998; 43: 174S-80S.
51. Kim H, Seo JY, Kim KH. Inhibition of lipid peroxidation, NF-κB activation and IL-8 production by rebamipide in Helicobacter pylori-stimulated gastric epithelial cells. Dig Dis Sci 2000; 45: 621-8.
52. Kim CD, Kim YK, Lee SH, Hong KW. Rebamipide inhibits neutrophil adhesion to hypoxia/reoxygenation-stimulated endothelial cells via nuclear factor-κB-dependent pathway. J Pharmacol Exp Ther 2000; 294: 864-9.